MetLife launches first standalone children's protection proposition

“We've certainly done something new in the market”

John Brazier
clock • 2 min read

MetLife has announced the launch of a new standalone protection policy, ChildShield, aimed at addressing current gaps in the market and offering advisers a complete protection proposition for clients.

Launched today (31 August), ChildShield is a standalone product covering children aged up to 23 for accidents and serious illness, including stepchildren and children who no longer live within the same household, designed to "complement" traditional protection products. The non-underwritten product includes cover for accidents such as broken bones or a 24-hour hospital stay, through to serious conditions including bacterial meningitis, cancer and benign brain tumours (see breakdown below). Speaking exclusively to COVER ahead of the launch, MetLife UK managing director Dominic Grinstea...

To continue reading this article...

Join COVER for free

  • Unlimited access to real-time news, key trend analysis and industry insights.
  • Stay on top of the latest developments around health and wellbeing, diversity and inclusion and the cost of living crisis.
  • Receive breaking news stories straight to your inbox in the daily newsletter.
  • Members only access to monthly programme 'The COVER Review'
  • Be the first to hear about our CPD accredited events and awards programmes.

Join now

 

Already a Cover member?

Login

More on Individual Protection

Underwritten WOL sees strong growth in Q3: Gen Re

Underwritten WOL sees strong growth in Q3: Gen Re

Growth in policies sold and APE

Cameron Roberts
clock 19 December 2025 • 1 min read
Octopus Legacy launches life cover with Shepherds Friendly

Octopus Legacy launches life cover with Shepherds Friendly

Designed to reduce anxiety

Jaskeet Briah
clock 10 December 2025 • 2 min read
Aviva updates online trust process

Aviva updates online trust process

Digitised trust for individual protection

Cameron Roberts
clock 28 November 2025 • 1 min read